[Cancer in @entity1 with celiac disease. @entity1593 in a @entity1 operated for XXXX ].

@entity1 @entity66 @entity706 @entity3935 @entity5 @entity1593 @entity391 @entity1661 @entity12878 @entity194 @entity3969 @entity204
In adults untreated @entity66 ( @entity66 ) is associated with a wide variety of malignant complications. The overall mortality in @entity66 is approximately twice that of the general population. The excess @entity204 are due mainly to @entity706 . In Europe, only 26 cases of @entity66 and @entity5 in @entity1 have been published. There is evidence that @entity5 and @entity66 in @entity1 are underreported. We report a case of @entity3969 in a @entity1 who developed @entity66 . As a neonate the @entity1 had been successfully operated for @entity12878 . Gluten was introduced in his diet at age of 12 months. He developed @entity391 , @entity1661 . Up to the age of 16 months he had lost 1500 g and @entity3935 was diagnosed (IgAEMA titre 1:50 and in the duodenal biopsy specimen there was crypt hyperplastic total @entity194 ). Symptoms improved rapidly when gluten-free diet was initiated, and 4 years later, clinical and serological findings were normal. @entity3969 accounts for 6% to 7% of all childhood @entity5 . There are no reports in MEDLINE about @entity66 in @entity1 who have been operated for the @entity5 . This seemed intriguing because prevalence of @entity1593 calculated for Europe varies between 1/100 and 1/300.
